Not Tagged
pfizer
['multiplemyeloma', 'thank you', 'pfizer']
thank you to everyone who joined us at #asco22 as we presented phase 2 data for the first time on our investigational bcma cd3-targeted bispecific antibody for those living with #multiplemyeloma. we are excited and hopeful for the future. learn more: 
News and information for healthcare professionals about Pfizer’s presence at scientific congresses. Please read: https://t.co/xwMAFDI5j5